ISOPRENE PHARMACEUTICALS INC
Baltimore, United States · Founded 2021 · $2.0M raised
- Headquarters
- Baltimore, Maryland
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2G
- Total Funding
- $2.0M
- Last Round
- $2.0M GrantJan 2021
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Isoprene Pharmaceuticals is an early-stage small molecule oncology company developing oral therapeutics for triple negative breast cancer and other cancers. The company is focused on novel Mnk1/2 protein degraders developed at the University of Maryland Baltimore. It is a spinout of the UMB New Ventures Initiative located at the University of Maryland BioPark. The company received a $2M NCI SBIR grant to advance pre-clinical studies toward an IND filing.
Summary
ISOPRENE PHARMACEUTICALS INC is a Biotech company based in Baltimore, United States, founded in 2021. It has raised $2.0M in total across 1 round, most recently a $2.0M Grant round in Jan 2021. Investors include National Cancer Institute.
Funding History
Jan 2021
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/isoprene-pharmaceuticals-inc"><img src="https://indexed.vc/api/badge/company/isoprene-pharmaceuticals-inc" alt="ISOPRENE PHARMACEUTICALS INC on Indexed.vc" width="260" height="76" /></a>